INFI Annual Accounts Receivable
N/A
31 December 2022
Summary:
INFI annual accounts receivable is not available.INFI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Accounts Receivable
N/A
30 June 2023
Summary:
INFI quarterly accounts receivable is not available.INFI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
INFI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Infinity Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $22.00 M(+3918.3%) |
| Mar 2011 | - | $547.50 K(+41.4%) |
| June 2010 | - | $387.10 K(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(-100.0%) |
| Mar 2009 | - | $6.22 M(-16.0%) |
| Dec 2008 | $7.41 M(+45.4%) | $7.41 M(+72.4%) |
| Sept 2008 | - | $4.30 M(-7.2%) |
| June 2008 | - | $4.64 M(-6.8%) |
| Mar 2008 | - | $4.97 M(-2.5%) |
| Dec 2007 | $5.10 M(-87.9%) | $5.10 M(-30.1%) |
| Sept 2007 | - | $7.30 M(+37.2%) |
| June 2007 | - | $5.32 M(-17.4%) |
| Mar 2007 | - | $6.44 M(-84.7%) |
| Dec 2006 | $42.13 M | $42.13 M(+12.6%) |
| Sept 2006 | - | $37.40 M(+1307.2%) |
| June 2006 | - | $2.66 M(+2.4%) |
| Mar 2006 | - | $2.60 M(-71.5%) |
| Sept 2005 | - | $9.12 M(-7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2005 | - | $9.82 M(+71.9%) |
| Mar 2005 | - | $5.71 M(-60.1%) |
| Dec 2004 | $14.33 M(+20.7%) | $14.33 M(+21.2%) |
| Sept 2004 | - | $11.83 M(-4.0%) |
| June 2004 | - | $12.32 M(+28.6%) |
| Mar 2004 | - | $9.58 M(-19.4%) |
| Dec 2003 | $11.87 M(+21.0%) | $11.87 M(+19.7%) |
| Sept 2003 | - | $9.92 M(+2.5%) |
| June 2003 | - | $9.68 M(-4.4%) |
| Mar 2003 | - | $10.12 M(+3.1%) |
| Dec 2002 | $9.82 M(-3.2%) | $9.82 M(-1.2%) |
| Sept 2002 | - | $9.93 M(+43.0%) |
| June 2002 | - | $6.95 M(-24.0%) |
| Mar 2002 | - | $9.14 M(-9.9%) |
| Dec 2001 | $10.14 M(+7.9%) | $10.14 M(+21.4%) |
| Sept 2001 | - | $8.36 M(-20.2%) |
| June 2001 | - | $10.48 M(+50.3%) |
| Mar 2001 | - | $6.97 M(-25.8%) |
| Dec 2000 | $9.40 M | $9.40 M |
FAQ
- What is the all time high annual accounts receivable for Infinity Pharmaceuticals?
- What is the all time high quarterly accounts receivable for Infinity Pharmaceuticals?
What is the all time high annual accounts receivable for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual accounts receivable is $42.13 M
What is the all time high quarterly accounts receivable for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly accounts receivable is $42.13 M